Boston Scientific (BSX) Depreciation and Depletion (2020 - 2026)

Boston Scientific has disclosed Depreciation and Depletion across 7 years of filings, most recently posting $29.0 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $29.0 million, up 7.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $394.0 million (up 12.89% YoY), and the FY2025 annual result was $471.0 million, up 14.32% from the prior year.
• Depreciation and Depletion came in at $29.0 million for Q1 2026 at Boston Scientific, down from $137.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $137.0 million in Q4 2025 to a low of $27.0 million in Q1 2025.
• The 5-year median for Depreciation and Depletion is $93.0 million (2023), against an average of $90.2 million.
• Across the five-year window, Depreciation and Depletion climbed 17.31% in 2024 and plunged 70.0% in 2025, its largest moves.
• Boston Scientific's Depreciation and Depletion stood at $95.0 million in 2022, then advanced by 9.47% to $104.0 million in 2023, then grew by 17.31% to $122.0 million in 2024, then gained by 12.3% to $137.0 million in 2025, then tumbled by 78.83% to $29.0 million in 2026.
• The last three Depreciation and Depletion figures came in at $29.0 million (Q1 2026), $137.0 million (Q4 2025), and $117.0 million (Q3 2025), per Business Quant data.